Clinical Trial: Study of Efficacy and Safety of AIN457/Secukinumab in Patients With Rotator Cuff Tendinopathy
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Tendinopathy
Study Type: INTERVENTIONAL
Official Title: A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter, 24-week Study Investigating the Efficacy and Safety of Secukinumab Compared to Placebo in Adult Patients With Moderate to S
Brief Summary:
The purpose of this study is to investigate the efficacy and safety of AIN457 (secukinumab s.c.) compared to placebo in adult patients with moderate to severe rotator cuff tendinopathy and failure to conventional therapy.The study duration will be 24 weeks.The treatment duration will 12 weeks with 12 weeks follow-up.The visit frequency will be weekly until visit 7 and 4-weekly until end of treatment and 4 follow-up visits.
Read more